Integrated DNA Technologies Inc

General

Total Cases1
Active Cases1
Patents92
TypeOperating Company
Elite Ratings
DCT

Ratings

Experience
Grade
Trend
DCT
L4
B
PTAB
L5
D
CAFC
L4
B

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
05/09/24
ORAL ORDER: IT IS HEREBY ORDERED that, not later than twenty (21) days from the date of this Order, the parties (with the exception of the Invitae Defendants to which these proceedings are stayed) shall meet and confer and file a joint proposed Scheduling Order in this action consistent with the applicable form Scheduling Order of Judge Williams, which is posted at http://www/ded/uscourts.gov (See Chambers, Judge Williams, Forms), along with a cover letter requesting the Court to enter the joint proposed Scheduling Order (if there are no disputes or other issues concerning scheduling that the Court needs to address) or to schedule the Rule 16 Scheduling Conference. If there are disputes or other issues the Court needs to address in the joint proposed Scheduling Order, in the cover letter, the parties shall direct the Court to the paragraph numbers in the joint proposed Scheduling Order which those appear. ORDERED by Judge Gregory B. Williams on 5/9/2024. (lnb) Modified on 5/9/2024 (lnb). (Entered: 05/09/2024)
05/08/24
Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding request for a Rule 26(f) conference and a Rule 16 scheduling conference. (Tigan, Jeremy) (Entered: 05/08/2024)
02/27/24
ANSWER to 27 Amended Answer to Complaint, Counterclaim by Tecan Genomics, Inc.. (Attachments: # 1 Exhibits A-J, # 2 Exhibits K-R)(Tigan, Jeremy) (Entered: 02/27/2024)
02/16/24
NOTICE of Suggestion of Bankruptcy for Invitae Corporation and Certain of its Affiliates and Automatic Stay of Proceedings by Invitae Corporation (Attachments: # 1 Exhibits A-B, # 2 Certificate of Service)(Silver, Daniel) (Entered: 02/16/2024)
02/13/24
AMENDED ANSWER to 16 Answer to Complaint, Counterclaim, COUNTERCLAIM against Tecan Genomics, Inc. by Integrated DNA Technologies, Inc.. (Joyce, Alexandra) (Entered: 02/13/2024)
01/26/24
EXHIBIT re 22 Answer to Counterclaim --Volume 2-- by Tecan Genomics, Inc.. (Attachments: # 1 Exhibit K, # 2 Exhibit L, # 3 Exhibit M, # 4 Exhibit N, # 5 Exhibit O, # 6 Exhibit P, # 7 Exhibit Q, # 8 Exhibit R)(Tigan, Jeremy) (Entered: 01/26/2024)
01/26/24
EXHIBIT re 22 Answer to Counterclaim --Volume 1-- by Tecan Genomics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J)(Tigan, Jeremy) (Entered: 01/26/2024)
01/26/24
EXHIBIT re 21 Answer to Counterclaim --Volume 2-- by Tecan Genomics, Inc.. (Attachments: # 1 Exhibit K, # 2 Exhibit L, # 3 Exhibit M, # 4 Exhibit N, # 5 Exhibit O, # 6 Exhibit P, # 7 Exhibit Q, # 8 Exhibit R)(Tigan, Jeremy) (Entered: 01/26/2024)
01/26/24
EXHIBIT re 21 Answer to Counterclaim --Volume 1-- by Tecan Genomics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J)(Tigan, Jeremy) (Entered: 01/26/2024)
01/26/24
ANSWER to 18 Answer to Complaint, Counterclaim by Tecan Genomics, Inc..(Tigan, Jeremy) (Entered: 01/26/2024)